[Effect of anesthesia technique on blood loss in breast reduction-plasty. A study of 56 patients operated on by one surgeon].
Abstract
[UNLABELLED] Since we had the impression that there was an increase in blood loss during mammaplasties after a change in the anesthesiology department responsible, we conducted a study to compare 28 cases from each anesthesiology department. All operations were carried out by the first author in succession using the same operative technique. The two groups did not differ in age, BMI, operative time, weight of resected tissue or preoperative laboratory. Blood loss was calculated from the perioperative drop in hemoglobin and patient's blood volume. Blood pressure, heart rate, medication and intravenous fluid supply were obtained from the anesthetic protocols.
[RESULTS (MEANS AND STANDARD DEVIATIONS)] Group I (n = 28) and [Group II (n = 28)]: total resected tissue 1862 +/- 928 g [1912 +/- 791 g]; Hb-preop. 13.6 +/- 0.9 g/dl [13.8 +/- 0.8 g/dl]; Hb-postop. 10.8 +/- 1.3 g/dl [9.7 +/- 1.3 g/dl] P = 0.006; Blood loss 970 +/- 339 ml [1443 +/- 456 ml] P < 0.001. After exclusion of surgical or biological causes hemodynamic effects of the anesthetic techniques were suspected as the reason for the significant difference in blood loss. MAP was elevated only initially, while the heart rate was considerably elevated throughout the procedures in group II. During anesthesia with nitrous oxide and enflurane, the dose of enflurane in group I could be limited to 0.3-0.5% after initial i.v. administration of 60 to 100 micrograms sufentanil, while in group II without opioids doses of 0.5-2% were required. The well-known dose-dependent effect of enflurane on the peripheral vascular tone was not masked by vasoconstrictors at the operative site.
[CONCLUSIONS] Blood loss during mammaplasties can be affected considerably by the anaesthetic technique--even without deliberate hypotension. Sufentanil can indirectly reduce the blood loss by lowering the necessary dose of enflurane. Blood transfusions can be avoided at mammaplasties.
[RESULTS (MEANS AND STANDARD DEVIATIONS)] Group I (n = 28) and [Group II (n = 28)]: total resected tissue 1862 +/- 928 g [1912 +/- 791 g]; Hb-preop. 13.6 +/- 0.9 g/dl [13.8 +/- 0.8 g/dl]; Hb-postop. 10.8 +/- 1.3 g/dl [9.7 +/- 1.3 g/dl] P = 0.006; Blood loss 970 +/- 339 ml [1443 +/- 456 ml] P < 0.001. After exclusion of surgical or biological causes hemodynamic effects of the anesthetic techniques were suspected as the reason for the significant difference in blood loss. MAP was elevated only initially, while the heart rate was considerably elevated throughout the procedures in group II. During anesthesia with nitrous oxide and enflurane, the dose of enflurane in group I could be limited to 0.3-0.5% after initial i.v. administration of 60 to 100 micrograms sufentanil, while in group II without opioids doses of 0.5-2% were required. The well-known dose-dependent effect of enflurane on the peripheral vascular tone was not masked by vasoconstrictors at the operative site.
[CONCLUSIONS] Blood loss during mammaplasties can be affected considerably by the anaesthetic technique--even without deliberate hypotension. Sufentanil can indirectly reduce the blood loss by lowering the necessary dose of enflurane. Blood transfusions can be avoided at mammaplasties.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | breast reduction
|
유방성형술 | dict | 1 | |
| 해부 | blood
|
scispacy | 1 | ||
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | heart
|
scispacy | 1 | ||
| 해부 | Blood transfusions
|
scispacy | 1 | ||
| 해부 | breast
|
유방 | dict | 1 | |
| 합병증 | mammaplasties
|
scispacy | 1 | ||
| 약물 | nitrous oxide
|
C0028215
nitrous oxide
|
scispacy | 1 | |
| 약물 | enflurane
|
C0014277
enflurane
|
scispacy | 1 | |
| 약물 | sufentanil
|
C0143993
sufentanil
|
scispacy | 1 | |
| 약물 | vasoconstrictors
|
C0042397
Vasoconstrictor Agents
|
scispacy | 1 | |
| 약물 | intravenous fluid
|
scispacy | 1 | ||
| 약물 | [RESULTS
|
scispacy | 1 | ||
| 약물 | [Group II (n = 28)]: total resected tissue 1862 +/- 928 g [1912 +/- 791
|
scispacy | 1 | ||
| 약물 | [1443 +/- 456
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] Blood
|
scispacy | 1 | ||
| 질환 | blood loss
|
C0019080
Hemorrhage
|
scispacy | 1 | |
| 질환 | Blood loss 970 +/- 339 ml [1443 +/- 456 ml] P < 0.001
|
scispacy | 1 | ||
| 질환 | hypotension
|
C0020649
Hypotension
|
scispacy | 1 | |
| 질환 | breast reduction-plasty
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | hemoglobin
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 | ||
| 기타 | MAP
|
scispacy | 1 | ||
| 기타 | peripheral vascular
|
scispacy | 1 |
MeSH Terms
Adult; Anesthesia, Inhalation; Blood Coagulation Tests; Blood Loss, Surgical; Dose-Response Relationship, Drug; Enflurane; Female; Hemodynamics; Humans; Mammaplasty; Middle Aged; Nitrous Oxide; Sufentanil
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.